VPAS
Market Access/ Views & Analysis/ Views and analysis
Getting better at measuring international uptake of medicines?
Market Access/ Views & Analysis/ Views and analysis
What’s affordable anyway? The future of NHS drug spending
Market Access/ Views & Analysis/ Views and analysis
VPAS: Progress two years in and opportunities to improve over next three years
Leela Barham
ABPI, branded medicines, Department of Health & Social Care, NHS, VPAS
0 Comment
Market Access/ Views & Analysis/ Views and analysis
VPAS: Achievement so far on objectives for the economy and innovation
Leela Barham
ABPI, Department of Health and Social Care, medicines pricing, NHS, VPAS, VPAS series
0 Comment
Market Access/ Views & Analysis/ Views and analysis
VPAS: Achievements so far on affordability
Leela Barham
ABPI, NHS, Voluntary Scheme for Branded Medicines Pricing and Access, VPAS, VPAS series
0 Comment
Market Access/ Views & Analysis/ Views and analysis
VPAS: Achievement so far on objectives for patients
Leela Barham
ABPI, NHS, Voluntary Scheme for Branded Medicines Pricing and Access, VPAS, VPAS series
0 Comment
Market Access/ Views & Analysis/ Views and analysis
2021 – UK market access prospects
Leela Barham
market access, MHRA, NHS England, NICE, Project Orbis, VPAS
0 Comment
Market Access/ Views & Analysis/ Views and analysis